Data reveals mechanisms in our bodies that can help us fight viral pathogenesis.

The Health Physics Society has selected Jonathan Napier, a PNNL environmental health physicist, to serve as a delegate to the International Radiation Protection Association’s General Assembly.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

Samantha Erwin, a PNNL data scientist, was recently appointed to the Society for Industrial and Applied Mathematics Membership Committee.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Pacific Northwest may face increase in summer heat-dome-like stationary waves.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Combining X-ray-based techniques allows researchers to locate and characterize small concentrations of electrons in complex semiconductor films.

The convergence of artificial intelligence, cloud, and high-performance computing to accelerate scientific discovery is the focus of a multi-year collaboration between Microsoft and PNNL.

Elias Nakouzi brings 3D atomic force microcopy expertise to a project focused on understanding how hybrid bio-based nanomaterials assemble.

PNNL scientists took thousands of measurements of firefighters in training to learn more about how the body responds to vigorous exercise.

PNNL researchers are investigating the cybersecurity vulnerabilities of an increasingly smart food and agriculture sector.

The pathway of oxygen ion movement can be controlled based on the initial structure and substrate of strontium iron oxide thin films.

Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

PNNL researchers demonstrated a simple method to create stable, identical nanoparticles of PdTe2-like composition, which is known to be superconducting, on a WTe2 TMD support.

PNNL’s wide-ranging report maps the current nanobiotechnology landscape, flags potential concerns, and details the need for an organizing body to coordinate currently disparate disciplines.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Lauren Charles, a chief data scientist at PNNL, joined the editorial board of the largest open access journal published by Nature Research.